Dermata Therapeutics Inc
DRMA6.700USD
+0.250+3.88%
交易中 （美東）報價延遲15分鐘
40.42M總市值
虧損本益比TTM
關於 Dermata Therapeutics Inc 公司
Dermata Therapeutics, Inc. 是一家後期醫學皮膚病學公司。該公司專注於識別、開發和商業化用於治療醫學和美容皮膚病和疾病的藥物候選產品。其兩種候選產品 DMT310 和 DMT410 均採用其專有的多面 Spongilla 技術，用於局部治療各種皮膚病。其主要候選產品 DMT310 旨在利用其 Spongilla 技術每週治療一次各種皮膚病，其初始重點是治療尋常痤瘡，該病在美國的市場規模約爲 5000 萬患者。其第二種利用 Spongilla 技術的候選產品是 DMT410，即其組合療法。DMT410 旨在包括一次使用其專有海綿粉的治療，然後局部應用一次肉毒桿菌毒素以輸送到真皮層。
公司簡介
公司代碼DRMA
公司名稱Dermata Therapeutics Inc
上市日期Aug 13, 2021
CEOMr. Gerald T. (Gerry) Proehl
員工數量8
證券類型Ordinary Share
年結日Aug 13
公司地址3525 Del Mar Heights Rd., #322
城市SAN DIEGO
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編92130
電話18582230882
網址https://www.dermatarx.com/
公司代碼DRMA
上市日期Aug 13, 2021
CEOMr. Gerald T. (Gerry) Proehl
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. David F. Hale
Mr. David F. Hale
Lead Independent Director
Lead Independent Director
8.15K
--
Ms. Kyri K. Van Hoose
Ms. Kyri K. Van Hoose
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.87K
--
Mr. Gerald T. (Gerry) Proehl
Mr. Gerald T. (Gerry) Proehl
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
110.00
--
Dr. Wendell Wierenga, Ph.D.
Dr. Wendell Wierenga, Ph.D.
Independent Director
Independent Director
26.00
--
Ms. Kathleen D. (Kathy) Scott
Ms. Kathleen D. (Kathy) Scott
Independent Director
Independent Director
12.00
--
Dr. Christopher J. Nardo, Ph.D.
Dr. Christopher J. Nardo, Ph.D.
Senior Vice President, Chief Development Officer
Senior Vice President, Chief Development Officer
11.00
--
Cliff Mastricola
Cliff Mastricola
Investor Relations
Investor Relations
--
--
Dr. Maria Bedoya Toro Munera, Ph.D.
Dr. Maria Bedoya Toro Munera, Ph.D.
Senior Vice President - Regulatory Affairs & Quality Assurance
Senior Vice President - Regulatory Affairs & Quality Assurance
--
--
Ms. Mary M. Fisher
Ms. Mary M. Fisher
Independent Director
Independent Director
--
--
Dr. Steven J. Mento, Ph.D.
Dr. Steven J. Mento, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. David F. Hale
Mr. David F. Hale
Lead Independent Director
Lead Independent Director
8.15K
--
Ms. Kyri K. Van Hoose
Ms. Kyri K. Van Hoose
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.87K
--
Mr. Gerald T. (Gerry) Proehl
Mr. Gerald T. (Gerry) Proehl
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
110.00
--
Dr. Wendell Wierenga, Ph.D.
Dr. Wendell Wierenga, Ph.D.
Independent Director
Independent Director
26.00
--
Ms. Kathleen D. (Kathy) Scott
Ms. Kathleen D. (Kathy) Scott
Independent Director
Independent Director
12.00
--
Dr. Christopher J. Nardo, Ph.D.
Dr. Christopher J. Nardo, Ph.D.
Senior Vice President, Chief Development Officer
Senior Vice President, Chief Development Officer
11.00
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 8月2日 週六
更新時間: 8月2日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Proehl Investment Ventures LLC
12.54%
Armistice Capital LLC
6.44%
Fisher (Mary)
3.09%
Hale (David F)
1.28%
Van Hoose (Kyri K)
1.23%
Other
75.42%
持股股東
持股股東
佔比
Proehl Investment Ventures LLC
12.54%
Armistice Capital LLC
6.44%
Fisher (Mary)
3.09%
Hale (David F)
1.28%
Van Hoose (Kyri K)
1.23%
Other
75.42%
股東類型
持股股東
佔比
Corporation
12.54%
Hedge Fund
6.47%
Individual Investor
5.63%
Investment Advisor
1.10%
Investment Advisor/Hedge Fund
0.32%
Research Firm
0.24%
Other
73.71%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
27
1.68M
26.29%
+195.79K
2025Q1
28
1.68M
27.33%
+272.74K
2024Q4
32
78.09K
7.68%
+46.07K
2024Q3
33
30.60K
6.84%
-27.42K
2024Q2
35
56.93K
12.24%
+29.75K
2024Q1
37
29.18K
7.55%
-12.55K
2023Q4
38
44.19K
19.06%
+14.60K
2023Q3
41
30.91K
14.54%
-1.54K
2023Q2
41
33.48K
15.76%
+9.73K
2023Q1
38
19.00K
33.48%
-3.46K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Proehl Investment Ventures LLC
799.51K
12.54%
--
--
May 16, 2025
Armistice Capital LLC
411.00K
6.44%
+383.80K
+1411.03%
Mar 31, 2025
Fisher (Mary)
196.95K
3.09%
--
--
May 16, 2025
Hale (David F)
81.47K
1.28%
--
--
May 16, 2025
Van Hoose (Kyri K)
78.74K
1.23%
--
--
May 16, 2025
UBS Financial Services, Inc.
70.29K
1.1%
+56.42K
+406.63%
Mar 31, 2025
Geode Capital Management, L.L.C.
20.41K
0.32%
+12.00K
+142.70%
Mar 31, 2025
Edward Jones
12.00K
0.19%
+12.00K
--
Mar 31, 2025
Wells Fargo Advisors
2.00K
0.03%
-45.00
-2.20%
Mar 31, 2025
Tower Research Capital LLC
1.80K
0.03%
+402.00
+28.84%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
公告日期
類型
比率
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
